Antibiotic Combination Therapy with Levofloxacin and Piperacillin/Tazobactam

Introduction to Combination Therapy

The Surviving Sepsis Campaign guidelines recommend against combination therapy for routine treatment and suggest de-escalation with discontinuation of combination therapy within the first few days if clinical improvement occurs 1
The World Health Organization guidelines recommend either piperacillin/tazobactam OR ciprofloxacin/levofloxacin with metronidazole as separate options, not together 2, 6

In severe infections requiring broad-spectrum coverage, particularly in healthcare-associated infections with risk of multidrug-resistant organisms, combination therapy may be considered 2, 3
For specific clinical scenarios such as necrotizing fasciitis, combination therapy with vancomycin or linezolid plus piperacillin/tazobactam is recommended 4
For hospital-acquired pneumonia in patients at high risk of mortality or with prior antibiotic exposure, combination therapy may be considered 5

Piperacillin/tazobactam is recommended for severe intra-abdominal infections 2, 8
Piperacillin/tazobactam is recommended for hospital-acquired pneumonia 3, 5
Levofloxacin is recommended for community-acquired pneumonia 9
Levofloxacin is recommended for mild to moderate intra-abdominal infections (with metronidazole) 2, 10
Levofloxacin is recommended for diabetic foot infections 4

Fluoroquinolones (including levofloxacin) are considered second options due to resistance and safety concerns 2, 7
When combination therapy is initially used for septic shock, de-escalation is recommended within the first few days in response to clinical improvement 1
Using both agents simultaneously may promote antimicrobial resistance 7
Potential antagonism between beta-lactams and fluoroquinolones in some infections should be considered 1
Increased selection pressure for resistant organisms is a concern with combination therapy 7